Delivery Order SPE2DR25D3404-SPE2DR26F5V4K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $17.4K to supply Savella (milnacipran) 50 mg tablets in quantities of 60, with a completion date of January 7, 2026. The contract was awarded on January 6, 2026, using firm fixed-price pricing with no set-aside designation, meaning it was competitively awarded. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Savella 50 mg tablets (60-count packages) with a contract ceiling value of $1,362.60. This competitively awarded, firm fixed-price delivery order is set to complete by November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Savella (milnacipran) 25 mg tablets in a 60-count package, with a ceiling value of $7,351.78. This non-set-aside, competitively awarded contract employs firm fixed pricing and has an ultimate completion date of May 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Savella 50 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $1,412.55, is set to be completed by August 25, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a non-set-aside, competitively awarded procurement and serves as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Savella 25 mg tablets (60-count packaging) with a ceiling value of $4,676.17. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count) with a ceiling value of $1,579.59. The contract, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, is structured as a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Savella 100 mg tablets (60-count units) under a firm fixed-price contract valued at $1,791.48. The order was competitively awarded without set-aside designation and carries an ultimate completion date of November 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.50 to AmerisourceBergen Drug Corp for the supply of Savella 100 mg tablets (60-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5V4KDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 9, 2026, for the supply of Savella 100 mg tablets in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $2,307.72 and is scheduled for completion by January 12, 2026. The contract utilizes no set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location, leveraging the company's established capabilities as a major pharmaceutical distributor to federal medical procurement programs. This delivery order operates under AmerisourceBergen's parent company Cencora's larger Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999.99 million through December 2031. This comprehensive IDC enables the supply of a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare systems globally. The Savella order reflects routine pharmaceutical procurement to support Defense Health Agency operations and military treatment facilities, consistent with the company's established role as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/8/26 |